Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Current assets:
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Proceeds receivable from sale of discontinued operations, net
Contract assets, net
Prepaid expenses
Other current assets
Current assets of discontinued operations
Total current assets
Property and equipment, net
Intangible assets, net
Right of use assets, net
Deposits and other assets
Non-current assets of discontinued operations
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Short-term operating lease liabilities
Warrant liability
Deferred revenues
Current liabilities of discontinued operations
Convertible notes payable, net of debt issuance costs (Note 11) ($0 and $6,000,000 in principal as of December 31, 2025 and December 31, 2024 was held by a related party. Refer to Note 14)
Total current liabilities
Long-term operating lease liabilities
Other long-term liabilities
Convertible notes payable, net of debt issuance costs (Note 13) ($6,000,000 in principal is held by a related party. Refer to Note 16)
Non-current liabilities of discontinued operations
Total long-term liabilities
Total liabilities
Stockholders' equity:
Preferred Stock; par value $0.001; 5,000,000 Shares authorized; 0 issued and outstanding as of March 31, 2026 and December 31, 2025
Common Stock; par value $0.001; 95,000,000 Shares authorized; 31,240,881 issued and outstanding as of March 31, 2026 and 31,072,251 issued and outstanding as of December 31, 2025
Additional paid-in capital
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support